Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT05165706)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05165706 Sponsor: Stanford University Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05165706 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 35 and 65 years old
Your body weight falls into the overweight to moderately obese range (BMI between 25 and 35)
Your weight has been stable recently
You do not have diabetes

Who may not be able to join:

You have diabetes
You have a serious disease affecting a major organ (such as the heart, liver, or kidneys)
You have had liposuction or weight-loss surgery in the past
You currently have an eating disorder or psychiatric disorder
You are pregnant or breastfeeding
You drink heavily on a regular basis
Your weight has changed significantly in the past 12 weeks
You are currently taking weight loss medications, cholesterol-lowering drugs (statins), or steroid tablets taken by mouth
Your blood iron levels are too low (confirm with trial site)
Your fasting blood sugar level is 126 mg/dL or higher (confirm with trial site)
Your blood pressure is higher than 160/100 mmHg

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tracey McLaughlin, MD, Stanford University, Department of Medicine, Division of Endocrinology

Phone: 908-619-5381

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05165706

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 908-619-5381

More information: https://clinicaltrials.gov/study/NCT05165706

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 35 and 65 years old
Your body weight falls into the overweight to moderately obese range (BMI between 25 and 35)
Your weight has been stable recently
You do not have diabetes

Who may not be able to join:

You have diabetes
You have a serious disease affecting a major organ (such as the heart, liver, or kidneys)
You have had liposuction or weight-loss surgery in the past
You currently have an eating disorder or psychiatric disorder
You are pregnant or breastfeeding
You drink heavily on a regular basis
Your weight has changed significantly in the past 12 weeks
You are currently taking weight loss medications, cholesterol-lowering drugs (statins), or steroid tablets taken by mouth
Your blood iron levels are too low (confirm with trial site)
Your fasting blood sugar level is 126 mg/dL or higher (confirm with trial site)
Your blood pressure is higher than 160/100 mmHg

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

31 January 2019

Est. completion

30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline on the 2-stage Steady State Plasma Glucose test; Change from baseline on the radiographic measurement of visceral to subcutaneous (V:S) fat ratio; Change from baseline on the magnetic-resonance based measurement of intrahepatic lipid deposition; Change from peak weight on the 2-stage Steady State Plasma Glucose test; Change from baseline on the radiographic measurement of visceral to subcutaneous (V:S) fat ratio; Change from baseline on the magnetic-resonance based measurement of intrahepatic lipid deposition; Measurement of markers of lipid and carbohydrate metabolism and...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov